DiaMonTech Closes Financing Round To Finalize Development Of Portable Non-Invasive Glucose Monitor

A completely new way of measuring blood glucose

DiaMonTech AG

Co-Founder Thorsten Lubinski and Prof Dr Werner Mäntele

Berlin-based health tech company DiaMonTech has successfully closed a financing round, raising further millions with the Berlin based Moll Family GmbH in the lead. This investment will be instrumental in advancing their pioneering non-invasive glucose monitoring technology.

DiaMonTech is at the forefront of developing a groundbreaking method to measure biomarkers reagent-free - with focus on a portable medical device to monitor glucose non-invasively. It has secured a total of ~20 million Euros to date, including prominent investors like Samsung Ventures and US-based VC Unorthodox Ventures. The current round was led by Moll Family and saw participation from new and existing investors. The raised funds will be allocated to further refining the prototype of their handheld device, D-Pocket, conducting critical clinical studies, and expediting market entry in the US and EU.

Empowering Tomorrow’s Health

DiaMonTech's vision is to unlock continuous health data collection for everyone. CEO Thorsten Lubinski emphasizes that their journey includes miniaturization of the sensor and the development of a wearable wristband that offers continuous blood glucose monitoring, data logging, and alarm functions, ultimately transforming how individuals manage their health.

Moll Family - Enabling Ambitious Minds

The Moll Family, based in Berlin, acts as a wealth management company with purpose, added value and responsibility. It sees itself as an organization of people who want to create change and make a difference. As an innovation enabler, the focus is on entrepreneurial ideas, technical research and development, with a positive impact on the environment.

"We are delighted to support DiaMonTech's journey. This disruptive approach promises a completely new way of measuring blood glucose and dealing with the associated diseases," says its founder Rolf-Jürgen Moll.

First Steps To US Expansion Through German Accelerator Program

To prepare for market entry in the US, DiaMonTech is proud to announce its participation in the German Accelerator Life Science Program, a market access initiative tailored for life sciences startups. This program is designed to assist in navigating the complexities of the US market, providing expert mentorship, and facilitating strategic connections. The program aligns with DiaMonTech's goals for international expansion, strategic partnerships, and successful market entry.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.